Mayne Pharma Group Ltd. | Income Statement
Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
143,254.00
141,420.00
267,280.00
572,595.00
530,313.00
Cost of Goods Sold (COGS) incl. D&A
73,137.00
69,960.00
115,249.00
323,988.00
346,140.00
Gross Income
70,117.00
71,460.00
152,031.00
248,607.00
184,173.00
SG&A Expense
40,486.00
56,521.00
96,530.00
126,343.00
147,052.00
EBIT
29,631.00
14,939.00
-
-
37,121.00
Unusual Expense
2,321.00
270.00
10,191.00
7,166.00
188,932.00
Non Operating Income/Expense
174.00
2,623.00
6,560.00
2,264.00
737.00
Interest Expense
4,349.00
5,945.00
2,494.00
11,517.00
15,825.00
Pretax Income
28,028.00
12,233.00
49,837.00
115,935.00
166,787.00
Income Tax
6,732.00
3,706.00
15,314.00
29,909.00
32,530.00
Equity in Affiliates
6.00
990.00
-
-
-
Consolidated Net Income
21,290.00
7,537.00
34,523.00
86,026.00
134,257.00
Net Income
21,290.00
7,759.00
37,355.00
88,567.00
133,984.00
Net Income After Extraordinaries
21,290.00
7,759.00
37,355.00
88,567.00
133,984.00
Net Income Available to Common
21,290.00
7,759.00
37,355.00
88,567.00
133,984.00
EPS (Basic)
0.03
0.01
0.05
0.06
0.09
Basic Shares Outstanding
620,334.10
689,969.50
782,397.00
1,433,643.00
1,462,867.00
EPS (Diluted)
0.03
0.01
0.05
0.06
0.09
Diluted Shares Outstanding
641,447.90
710,900.90
809,347.00
1,460,349.00
1,462,867.00
EBITDA
39,490.00
28,441.00
76,878.00
195,932.00
117,004.00
Non-Operating Interest Income
251.00
355.00
461.00
286.00
112.00
Minority Interest Expense
-
222.00
2,832.00
2,541.00
273.00
About Mayne Pharma Group
View Profile
